Here are five orthopedic and sports medicine surgeons using Lipogems, an FDA-cleared technology that uses the body's own adipose tissue to help heal injuries.
Biologics
Kuros Biosciences entered into a private label agreement with SeaSpine.
Robert Watkins Jr., MD, performed his first surgery with the Osseus Fusion Systems Aries-L technology, which is currently in alpha launch.
Ann Arbor-based Michigan Medicine researchers are working to improve the Masquelet orthopedic surgical technique, according to MHealth Lab.
Mark Miller, MD, is an orthopedic sports medicine surgeon and orthopedic surgery professor at the University of Virginia in Charlottesville.
Sirakoss received CE mark approval for its Osteo3, a new nano-synthetic bone graft substitute designed for use in bone fracture repair.
Seth L. Sherman, MD, enrolled and operated on four patients in a study of CartiHeal's Agili-C knee cartilage repair implant.
Orthobiologics company Biogennix named Robert Bazier its new CFO.
Regenerative medicine company CollPlant appointed Jonathan M.N. Rigby as chairman of the board of directors.
Ortho Regenerative Technologies published the results of two scientific studies validating its product's ability to improve the repair of rotator cuff tendon and articular cartilage tissue.
